Exothera
Jumet, BE
Program data pending ClinicalTrials.gov matching
· Last scored 2026-10-29
78.1
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
○ Press
✓ EMA GMP (4)
○ MHRA GMP
Quick Facts: Exothera
- Signal Score
- 78.1/100 (as of 2026-10-29)
- Quality Compliance
- 100.0/100 — Clean EMA record: 4 active GMP certificates (no deductions)
- Headquarters
- Jumet, BE
- Modalities
- AAV, Adenoviral, Lentiviral
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Exothera
Belgian viral vector CDMO.
Signal Score & Pillar Breakdown
Quality Compliance
100.0
Clean EMA record: 4 active GMP certificates (no deductions)
Sources: FDA Data Dashboard, EMA EudraGMDP
Clean EMA record: 4 active GMP certificates (no deductions)
FDA InspectionsNo US records on file
EMA GMP Certificates4 on record
Clean EMA record: 4 active GMP certificates (no deductions)
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesAAV, Adenoviral, Lentiviral
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Scored from ClinicalTrials.gov and FDA records; SEC EDGAR and press items are shown as company signals, not scored. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
58.0
1 manufacturing site: Jumet, Belgium
Modalities: AAV, Adenoviral, Lentiviral
Capacity assessment: 58.0/100
Sites: Jumet, Belgium
Source: company profiles (manufacturing sites, modality breadth)
1 manufacturing site
1 manufacturing site: Jumet, Belgium
Modalities: AAV, Adenoviral, Lentiviral
Capacity assessment: 58.0/100
Exothera EMA GMP Compliance 4 certificates
2023-11
2023-11
2023-11
2023-11
Compliant
Non-Compliant
| Certificate | Site | Country | Inspection Date | Status |
|---|---|---|---|---|
| BE/GMP/2023/128 | Exothera | Belgium | 2023-11-24 | COMPLIANT |
| BE/GMP/2023/129 | Exothera | Belgium | 2023-11-24 | COMPLIANT |
| BE/GMP/2023/131 | Exothera | Belgium | 2023-11-24 | COMPLIANT |
| BE/GMP/2023/130 | Exothera | Belgium | 2023-11-24 | COMPLIANT |
Source: EMA EudraGMDP · Retrieved Nov 21, 2026
Hiring Activity Beta
Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data. This company's careers site asks automated readers not to collect it (robots.txt), and we respect that.
Source:
public careers pages
· Checked Nov 20, 2026
Frequently Asked Questions About Exothera
Does Exothera hold EMA or MHRA GMP certificates?
CDMO Signal tracks 4 EMA GMP certificates for Exothera.
What is Exothera's CDMO Signal Score?
Exothera has a Signal Score of 78/100, based on quality, operations, financial stability, and capacity data.
Evaluating Exothera for a manufacturing program?
Use the free AI matchmaker to compare Exothera against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
SK pharmteco
Dublin, Ireland. Rancho Cordova, CA. King of Prussia, PA. Houston, TX. Korea. France.
Signal Score: 79.5
Viral Vectors, AAV, Lentiviral, Adenoviral, HPAPIs, Small Molecules, Peptides, BioCatalysis, Chromatography, Cell Therapy
Advent Bioservices
London, United Kingdom
Signal Score: 78.1
AAV, Lentiviral, Adenoviral
Thermo Fisher Scientific
Plainville, MA · Alachua, FL · Cambridge, MA
Signal Score: 77.6
AAV, Lentiviral, Plasmid DNA, Adenoviral, Plasmid, Small Molecule API, Oral Solid Dose, Sterile Fill-Finish
Rose BioSolutions
Rockville, MD · Memphis, TN · Keele, United Kingdom
Signal Score: 64.0
AAV, Lentiviral, Adenoviral, Plasmid, Cell Therapy, CAR-T
Pharmaron
San Diego, CA · Shaoxing, China, Liverpool, UK, Ningbo China
Signal Score: 86.9
AAV, Lentiviral, Plasmid, mAb, Antibody, Recombinant Protein, Biosimilars
Compare Exothera with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.